Xin Y - Search Results

1

Comparison of rapamycin versus FK506 on expression of cytoprotective genes in the rat kidney allografts undergoing chronic allograft nephropathy.

Teng D, Lu Y, Gao R, Xin Y, Cao G, Li X, Wang L, Wang J, Li Y. Teng D, et al. Among authors: xin y. Transplant Proc. 2006 Sep;38(7):2172-5. doi: 10.1016/j.transproceed.2006.06.008. Transplant Proc. 2006. PMID: 16980034

2

Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection.

Cao G, Lu Y, Gao R, Xin Y, Teng D, Wang J, Li Y. Cao G, et al. Among authors: xin y. Transplant Proc. 2006 Sep;38(7):1998-2000. doi: 10.1016/j.transproceed.2006.06.081. Transplant Proc. 2006. PMID: 16979977

3

Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection.

Teng D, Lu Y, Gao R, Xin Y, Cao G, Li X, Wang L, Wang J, Wang L, Li Y. Teng D, et al. Among authors: xin y. Transplant Proc. 2006 Sep;38(7):2164-7. doi: 10.1016/j.transproceed.2006.06.007. Transplant Proc. 2006. PMID: 16980032

4

Comparison of cyclosporine versus mycophenolate mofetil on expression of Fractalkine and CX3CR1 in chronic allograft nephropathy.

Cao G, Lu Y, Gao R, Xin Y, Teng D, Wang J, Wang L, Li Y. Cao G, et al. Among authors: xin y. Transplant Proc. 2006 Sep;38(7):2234-6. doi: 10.1016/j.transproceed.2006.06.046. Transplant Proc. 2006. PMID: 16980051

5

A biocompatible nanoparticle-based approach to inhibiting renal ischemia reperfusion injury in mice by blocking thrombospondin-1 activity.

Hou Y, Xin Y, Liu S, Li Y, Meng X, Wang J, Xu Z, Sun T, Yang YG. Hou Y, et al. Among authors: xin y. Am J Transplant. 2022 Sep;22(9):2246-2253. doi: 10.1111/ajt.17052. Epub 2022 Apr 18. Am J Transplant. 2022. PMID: 35373451 Free article.

6

Kidney functional stages influence the role of PEG end-group on the renal accumulation and distribution of PEGylated nanoparticles.

Xin Y, Hou Y, Cong X, Tan H, Wang J, Mao K, Wang X, Liu F, Yang YG, Sun T. Xin Y, et al. Nanoscale. 2022 Jul 7;14(26):9379-9391. doi: 10.1039/d2nr02194c. Nanoscale. 2022. PMID: 35727088

7

Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes.

Wang X, Meng X, Mao K, Chen H, Cong X, Liu F, Wang J, Liu S, Xin Y, Zhu G, Tan H, Yang YG, Sun T. Wang X, et al. Among authors: xin y. Biomaterials. 2023 Sep;300:122187. doi: 10.1016/j.biomaterials.2023.122187. Epub 2023 May 31. Biomaterials. 2023. PMID: 37302279

8

In Vivo Immune Adjuvant Effects of CaCO₃ Nanoparticles through Intracellular Ca²⁺ Concentration Regulation.

Tan H, Mao K, Cong X, Xin Y, Liu F, Wang J, Wang X, Han J, Zhang Y, Yang YG, Sun T. Tan H, et al. Among authors: xin y. ACS Appl Mater Interfaces. 2023 Aug 23;15(33):39157-39166. doi: 10.1021/acsami.3c07306. Epub 2023 Aug 8. ACS Appl Mater Interfaces. 2023. PMID: 37553750

9

Impacts of cationic lipid-DNA complexes on immune cells and hematopoietic cells in vivo.

Cong X, Tan H, Lv Y, Mao K, Xin Y, Wang J, Meng X, Guan M, Wang H, Yang YG, Sun T. Cong X, et al. Among authors: xin y. Biomater Sci. 2024 Apr 30;12(9):2381-2393. doi: 10.1039/d4bm00148f. Biomater Sci. 2024. PMID: 38500446

10

Co-delivery of vitamin D3 and Lkb1 siRNA by cationic lipid-assisted PEG-PLGA nanoparticles to effectively remodel the immune system in vivo.

Liu H, Zhang Y, Li H, Gao X, Wang J, Cong X, Xin Y, Zhu Q, Chen B, Yang YG, Sun T. Liu H, et al. Among authors: xin y. Biomater Sci. 2023 Aug 22;11(17):5931-5941. doi: 10.1039/d3bm00767g. Biomater Sci. 2023. PMID: 37470222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,592 results

Search Page

Filters